FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4323075062> ?p ?o ?g. }

• W4323075062 abstract "Abstract Background Platelets play a critical role in the formation of thrombosis and embolism, and high-sensitivity C-reactive protein (HS-CRP) is an important indicator of inflammation, which contribute to the development of ischemic stroke development. This study aimed to examine whether the relationship between baseline platelet count and adverse clinical outcomes is modulated by HS-CRP in patients with ischemic stroke. Methods A total of 3267 patients with ischemic stroke were included in the analysis. The primary outcome was a combination of death and major disability (modified Rankin Scale [mRS] score ≥3) at 1 year after ischemic stroke. Secondary outcomes included major disability, death, vascular events, composite outcome of vascular events or death, and an ordered 7-level categorical score of the mRS at 1 year. Multivariate logistic regression and Cox proportional hazards regression models were used to assess the association between the baseline platelet count and clinical outcomes stratified by HS-CRP levels when appropriate, odds ratio (OR) or hazard ratio (HR) and 95% confidence interval (CI) were calculated for the highest quartiles of platelet counts compared with the lowest quartile. Results The elevated platelet count was associated with the primary outcome (OR, 3.14;95% CI, 1.77-5.58), major disability (OR, 2.07;95%CI, 1.15-3.71), death (HR, 2.75;95%CI, 1.31-5.79), composite outcome of vascular events or death (HR, 2.57;95%CI, 1.38-4.87), and the ordered 7-level categorical score of the mRS at 1 year (OR, 2.01 [95%CI, 1.33-3.04]) among patients with high HS-CRP levels (all P trend <0.05). However, platelet count was not associated with the primary outcome (OR, 1.13; 95%CI, 0.75-1.71), major disability (OR, 1.34; 95%CI, 0.87-2.08), death (HR, 0.48; 95%CI, 0.19-1.24), composite outcome of vascular events or death (HR, 0.79; 95%CI, 0.45-1.37), and the ordered 7-level categorical score of the mRS at 1 year (OR, 1.17; 95%CI, 0.91-1.49) (all P trend >0.05) in those with low HS-CRP levels. There was an interaction effect of platelet count and HS-CRP on the primary outcome, death, composite outcome of vascular events or death, and the ordered 7-level categorical score of the mRS at 1 year after ischemic stroke (all P interaction <0.05). Conclusions An elevated platelet count was associated with adverse clinical outcomes in ischemic stroke patients with high HS-CRP levels but not in those with low HS-CRP levels, the HS-CRP level had a modifying effect on the association between platelet count and clinical outcomes in patients with ischemic stroke, suggesting that strategies for anti-inflammatory and antiplatelet therapy should be developed according to the results of both platelet and HS-CRP testing." @default.
• W4323075062 created "2023-03-05" @default.
• W4323075062 creator A5007808630 @default.
• W4323075062 creator A5032536896 @default.
• W4323075062 creator A5036414819 @default.
• W4323075062 creator A5039086738 @default.
• W4323075062 creator A5040144057 @default.
• W4323075062 creator A5045612936 @default.
• W4323075062 creator A5046465494 @default.
• W4323075062 creator A5048123391 @default.
• W4323075062 creator A5056763935 @default.
• W4323075062 creator A5058932447 @default.
• W4323075062 creator A5059533675 @default.
• W4323075062 creator A5067704857 @default.
• W4323075062 creator A5068949602 @default.
• W4323075062 date "2023-03-01" @default.
• W4323075062 modified "2023-10-14" @default.
• W4323075062 title "High-sensitivity C-reactive protein modifies the prognostic value of platelet count for clinical outcomes after ischemic stroke" @default.
• W4323075062 cites W1978901235 @default.
• W4323075062 cites W2023572242 @default.
• W4323075062 cites W2030472502 @default.
• W4323075062 cites W2031350146 @default.
• W4323075062 cites W2043976791 @default.
• W4323075062 cites W2047791325 @default.
• W4323075062 cites W2050798863 @default.
• W4323075062 cites W2053840916 @default.
• W4323075062 cites W2056404114 @default.
• W4323075062 cites W2069492532 @default.
• W4323075062 cites W2073575970 @default.
• W4323075062 cites W2074914768 @default.
• W4323075062 cites W2080504768 @default.
• W4323075062 cites W2094941678 @default.
• W4323075062 cites W2098787760 @default.
• W4323075062 cites W2106276722 @default.
• W4323075062 cites W2119363292 @default.
• W4323075062 cites W2137983259 @default.
• W4323075062 cites W2138595885 @default.
• W4323075062 cites W2144710774 @default.
• W4323075062 cites W2146243209 @default.
• W4323075062 cites W2146336916 @default.
• W4323075062 cites W2157595656 @default.
• W4323075062 cites W2173037893 @default.
• W4323075062 cites W2297100155 @default.
• W4323075062 cites W2412702708 @default.
• W4323075062 cites W2467221973 @default.
• W4323075062 cites W2510717732 @default.
• W4323075062 cites W2587693914 @default.
• W4323075062 cites W2591359967 @default.
• W4323075062 cites W2784146546 @default.
• W4323075062 cites W2904567630 @default.
• W4323075062 cites W2908650877 @default.
• W4323075062 cites W2939674755 @default.
• W4323075062 cites W3009071683 @default.
• W4323075062 cites W3012135011 @default.
• W4323075062 cites W3083125992 @default.
• W4323075062 cites W3091512034 @default.
• W4323075062 cites W3179605762 @default.
• W4323075062 cites W3185165648 @default.
• W4323075062 cites W3197233575 @default.
• W4323075062 cites W3213988304 @default.
• W4323075062 doi "https://doi.org/10.1101/2023.02.27.23286541" @default.
• W4323075062 hasPublicationYear "2023" @default.
• W4323075062 type Work @default.
• W4323075062 citedByCount "0" @default.
• W4323075062 crossrefType "posted-content" @default.
• W4323075062 hasAuthorship W4323075062A5007808630 @default.
• W4323075062 hasAuthorship W4323075062A5032536896 @default.
• W4323075062 hasAuthorship W4323075062A5036414819 @default.
• W4323075062 hasAuthorship W4323075062A5039086738 @default.
• W4323075062 hasAuthorship W4323075062A5040144057 @default.
• W4323075062 hasAuthorship W4323075062A5045612936 @default.
• W4323075062 hasAuthorship W4323075062A5046465494 @default.
• W4323075062 hasAuthorship W4323075062A5048123391 @default.
• W4323075062 hasAuthorship W4323075062A5056763935 @default.
• W4323075062 hasAuthorship W4323075062A5058932447 @default.
• W4323075062 hasAuthorship W4323075062A5059533675 @default.
• W4323075062 hasAuthorship W4323075062A5067704857 @default.
• W4323075062 hasAuthorship W4323075062A5068949602 @default.
• W4323075062 hasBestOaLocation W43230750621 @default.
• W4323075062 hasConcept C126322002 @default.
• W4323075062 hasConcept C127413603 @default.
• W4323075062 hasConcept C156957248 @default.
• W4323075062 hasConcept C164705383 @default.
• W4323075062 hasConcept C207103383 @default.
• W4323075062 hasConcept C2776914184 @default.
• W4323075062 hasConcept C2780645631 @default.
• W4323075062 hasConcept C2780931571 @default.
• W4323075062 hasConcept C2781195455 @default.
• W4323075062 hasConcept C3020199598 @default.
• W4323075062 hasConcept C44249647 @default.
• W4323075062 hasConcept C50382708 @default.
• W4323075062 hasConcept C541997718 @default.
• W4323075062 hasConcept C68443243 @default.
• W4323075062 hasConcept C71924100 @default.
• W4323075062 hasConcept C78519656 @default.
• W4323075062 hasConceptScore W4323075062C126322002 @default.
• W4323075062 hasConceptScore W4323075062C127413603 @default.
• W4323075062 hasConceptScore W4323075062C156957248 @default.
• W4323075062 hasConceptScore W4323075062C164705383 @default.
• W4323075062 hasConceptScore W4323075062C207103383 @default.

• next